Grassi Investment Management / ABT
Grassi Investment Management’s Abbott Laboratories Position
Does Grassi Investment Management own Abbott Laboratories (ABT)? Yes — 121.4K shares worth $17M (+1.31% of its 13F portfolio) as of Q2 2025, down from 122.4K shares the prior filed quarter.
Position Value
$17M
Q2 2025
Shares
121.4K
% of Portfolio
+1.31%
Quarters Held
27
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2025 | 121.4K | $17M | +1.31% |
| Q1 2025 | 122.4K | $16M | +1.50% |
| Q4 2024 | 123.1K | $14M | +1.19% |
| Q3 2024 | 124.6K | $14M | +1.23% |
| Q2 2024 | 125.3K | $13M | +1.15% |
| Q1 2024 | 111.9K | $13M | +1.15% |
| Q4 2023 | 111.8K | $12M | +1.29% |
| Q3 2023 | 111.8K | $11M | +1.25% |
| Q2 2023 | 111.9K | $12M | +1.34% |
| Q1 2023 | 111.9K | $11M | +1.41% |
| Q4 2022 | 112.1K | $12M | +1.66% |
| Q3 2022 | 112.2K | $11M | +1.58% |
| Q2 2022 | 112.5K | $12M | +1.61% |
| Q1 2022 | 113.2K | $13M | +1.40% |
| Q4 2021 | 113.3K | $16M | +1.59% |
| Q3 2021 | 113.1K | $13M | +1.50% |
| Q2 2021 | 112.6K | $13M | +1.42% |
| Q1 2021 | 112.6K | $13M | +1.53% |
| Q4 2020 | 113.0K | $12M | +1.57% |
| Q3 2020 | 115.8K | $13M | +1.79% |
| Q2 2020 | 118.2K | $11M | +1.56% |
| Q1 2020 | 119.5K | $9M | +1.65% |
| Q4 2019 | 121.4K | $11M | +1.43% |
| Q3 2019 | 122.3K | $10M | +1.53% |
| Q2 2019 | 123.5K | $10M | +1.53% |
| Q1 2019 | 123.4K | $10M | +1.46% |
| Q4 2018 | 123.1K | $9M | +1.53% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Grassi Investment Management’s full portfolio or all institutional holders of ABT.